The DNA damage response and cancer therapy

CJ Lord, A Ashworth - Nature, 2012 - nature.com
Genomic instability is one of the most pervasive characteristics of tumour cells and is
probably the combined effect of DNA damage, tumour-specific DNA repair defects, and a …

TET proteins and the control of cytosine demethylation in cancer

L Scourzic, E Mouly, OA Bernard - Genome medicine, 2015 - Springer
The discovery that ten-eleven translocation (TET) proteins are α-ketoglutarate-dependent
dioxygenases involved in the conversion of 5-methylcytosines (5-mC) to 5 …

Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor

SMA Islam, M Díaz-Gay, Y Wu, M Barnes, R Vangara… - Cell genomics, 2022 - cell.com
Mutational signature analysis is commonly performed in cancer genomic studies. Here, we
present SigProfilerExtractor, an automated tool for de novo extraction of mutational …

A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors

J Zhou, C Gelot, C Pantelidou, A Li, H Yücel, RE Davis… - Nature cancer, 2021 - nature.com
DNA polymerase theta (POLθ or POLQ) is synthetic lethal with homologous recombination
(HR) deficiency and is thus a candidate target for HR-deficient cancers. Through high …

Strong suppression of gene conversion with increasing DNA double-strand break load delimited by 53BP1 and RAD52

E Mladenov, C Staudt, A Soni… - Nucleic acids …, 2020 - academic.oup.com
In vertebrates, genomic DNA double-strand breaks (DSBs) are removed by non-
homologous end-joining processes: classical non-homologous end-joining (c-NHEJ) and …

Distinct binding of BRCA2 BRC repeats to RAD51 generates differential DNA damage sensitivity

G Chatterjee, J Jimenez-Sainz, T Presti… - Nucleic Acids …, 2016 - academic.oup.com
BRCA2 is a multi-faceted protein critical for the proper regulation of homology-directed
repair of DNA double-strand breaks. Elucidating the mechanistic features of BRCA2 is …

A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer

Y Wang, JYP Park, A Pacis, RE Denroche… - Clinical Cancer …, 2020 - AACR
Purpose: Pancreatic ductal adenocarcinoma (PDAC) arising in patients with a germline
BRCA1 or BRCA2 (g BRCA) mutation may be sensitive to platinum and PARP inhibitors …

A whole‐genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor‐negative and ‐positive breast cancers

R Natrajan, A Mackay, MB Lambros… - The Journal of …, 2012 - Wiley Online Library
BRCA1 encodes a tumour suppressor protein that plays pivotal roles in homologous
recombination (HR) DNA repair, cell‐cycle checkpoints, and transcriptional regulation …

The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes

TP Slavin, SL Neuhausen, B Nehoray, M Niell-Swiller… - Familial cancer, 2018 - Springer
Abstract Approximately 5–10% of all pancreatic cancer patients carry a predisposing
mutation in a known susceptibility gene. Since> 90% of patients present with late stage …

[HTML][HTML] DMPC/Chol liposomal copper CX5461 is therapeutically superior to a DSPC/Chol formulation

AWY Leung, KTJ Chen, GM Ryan, M Anantha… - Journal of Controlled …, 2022 - Elsevier
CX5461, a compound initially identified as an RNA polymerase inhibitor and more recently
as a G-quadruplex binder, binds copper to form a complex. Our previous publication showed …